Found: 39
Select item for more details and to access through your institution.
Guidance on current good radiopharmacy practice for the small-scale preparation of radiopharmaceuticals using automated modules: a European perspective.
- Published in:
- 2014
- By:
- Publication type:
- Other
Feasibility of the radioastatination of a monoclonal antibody with astatine-211 purified by wet extraction.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2008, v. 51, n. 11, p. 379, doi. 10.1002/jlcr.1543
- By:
- Publication type:
- Article
Synthesis and evaluation of a novel samarium-153 bifunctional chelating agent for radioimmunotargeting applications.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2006, v. 49, n. 2, p. 109, doi. 10.1002/jlcr.1031
- By:
- Publication type:
- Article
Radioimmunotherapy of B-cell non-Hodgkin's lymphoma.
- Published in:
- Frontiers in Oncology, 2013, v. 3, p. 1, doi. 10.3389/fonc.2013.00177
- By:
- Publication type:
- Article
Preclinical Evaluation of a 64 Cu-Based Theranostic Approach in a Murine Model of Multiple Myeloma.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 7, p. 1817, doi. 10.3390/pharmaceutics15071817
- By:
- Publication type:
- Article
Impact of DOTA Conjugation on Pharmacokinetics and Immunoreactivity of [ 177 Lu]Lu-1C1m-Fc, an Anti TEM-1 Fusion Protein Antibody in a TEM-1 Positive Tumor Mouse Model.
- Published in:
- Pharmaceutics, 2021, v. 13, n. 1, p. 96, doi. 10.3390/pharmaceutics13010096
- By:
- Publication type:
- Article
What is the Best Radionuclide for Immuno-PET of Multiple Myeloma? A Comparison Study Between 89Zr- and 64Cu-Labeled Anti-CD138 in a Preclinical Syngeneic Model.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 10, p. 2564, doi. 10.3390/ijms20102564
- By:
- Publication type:
- Article
Immuno-PET for Clinical Theranostic Approaches.
- Published in:
- International Journal of Molecular Sciences, 2017, v. 18, n. 1, p. 57, doi. 10.3390/ijms18010057
- By:
- Publication type:
- Article
Tumor Immunotargeting Using Innovative Radionuclides.
- Published in:
- International Journal of Molecular Sciences, 2015, v. 16, n. 2, p. 3932, doi. 10.3390/ijms16023932
- By:
- Publication type:
- Article
Highlight selection of radiochemistry and radiopharmacy developments by editorial board.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2021, v. 6, n. 1, p. 1, doi. 10.1186/s41181-021-00146-9
- By:
- Publication type:
- Article
Comparative targeting of human colon-carcinoma multicell spheroids using one- and two-step (bispecific antibody) techniques.
- Published in:
- International Journal of Cancer, 1996, v. 67, n. 6, p. 883, doi. 10.1002/(SICI)1097-0215(19960917)67:6<883::AID-IJC20>3.0.CO;2-1
- By:
- Publication type:
- Article
Use of multi-cell spheroids of ovarian carcinoma as an intraperitoneal radio-immunotherapy model: Uptake, retention kinetics and dosimetric evaluation.
- Published in:
- International Journal of Cancer, 1992, v. 50, n. 6, p. 984, doi. 10.1002/ijc.2910500627
- By:
- Publication type:
- Article
From bench to bedside: <sup>64</sup>Cu/<sup>177</sup>Lu 1C1m-Fc anti TEM-1: mice-to-human dosimetry extrapolations for future theranostic applications.
- Published in:
- EJNMMI Research, 2023, v. 13, n. 1, p. 1, doi. 10.1186/s13550-023-01010-4
- By:
- Publication type:
- Article
Combining α-Radioimmunotherapy and Adoptive T Cell Therapy to Potentiate Tumor Destruction.
- Published in:
- PLoS ONE, 2015, v. 10, n. 6, p. 1, doi. 10.1371/journal.pone.0130249
- By:
- Publication type:
- Article
Copper-64-Labeled 1C1m-Fc, a New Tool for TEM-1 PET Imaging and Prediction of Lutetium-177-Labeled 1C1m-Fc Therapy Efficacy and Safety.
- Published in:
- Cancers, 2021, v. 13, n. 23, p. 5936, doi. 10.3390/cancers13235936
- By:
- Publication type:
- Article
Antibody-Hapten Recognition at the Surface of Functionalized Liposomes Studied by SPR: Steric Hindrance of Pegylated Phospholipids in Stealth Liposomes Prepared for Targeted Radionuclide Delivery.
- Published in:
- Journal of Drug Delivery, 2011, p. 1, doi. 10.1155/2011/368535
- By:
- Publication type:
- Article
[<sup>68</sup>Ga]Ga‐PentixaFor: Development of a fully automated in hospital production on the Trasis miniAllinOne synthesizer.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2023, v. 66, n. 12, p. 400, doi. 10.1002/jlcr.4061
- By:
- Publication type:
- Article
Comparison of the biologic effects of MA5 and B-B4 monoclonal antibody labeled with iodine-131 and bismuth-213 on multiple myeloma.
- Published in:
- Cancer (0008543X), 2002, v. 94, n. S4, p. 1202, doi. 10.1002/cncr.10286
- By:
- Publication type:
- Article
EANM guideline for the preparation of an Investigational Medicinal Product Dossier (IMPD).
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2014, v. 41, n. 11, p. 2175, doi. 10.1007/s00259-014-2866-8
- By:
- Publication type:
- Article
Pretargeted radioimmunotherapy of colorectal cancer metastases: models and pharmacokinetics predict influence of the physical and radiochemical properties of the radionuclide.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2011, v. 38, n. 12, p. 2153, doi. 10.1007/s00259-011-1903-0
- By:
- Publication type:
- Article
Guidance on current good radiopharmacy practice (cGRPP) for the small-scale preparation of radiopharmaceuticals.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2010, v. 37, n. 5, p. 1049, doi. 10.1007/s00259-010-1407-3
- By:
- Publication type:
- Article
Improved pretargeted delivery of radiolabelled hapten to human tumour xenograft in mice by avidin chase of circulating bispecific antibody.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2005, v. 32, n. 8, p. 901, doi. 10.1007/s00259-005-1811-2
- By:
- Publication type:
- Article
Cancer radioimmunotherapy with alpha-emitting nuclides.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2005, v. 32, n. 5, p. 601, doi. 10.1007/s00259-005-1803-2
- By:
- Publication type:
- Article
A pretargeting system for tumor PET imaging and radioimmunotherapy.
- Published in:
- Frontiers in Pharmacology, 2015, v. 6, p. 1, doi. 10.3389/fphar.2015.00054
- By:
- Publication type:
- Article
Immuno-PET Using Anticarcinoembryonic Antigen Bispecific Antibody and <sup>68</sup>Ga-Labeled Peptide in Metastatic Medullary Thyroid Carcinoma: Clinical Optimization of the Pretargeting Parameters in a First-in-Human Trial.
- Published in:
- Journal of Nuclear Medicine, 2016, v. 57, n. 10, p. 1505, doi. 10.2967/jnumed.116.172221
- By:
- Publication type:
- Article
Phase II Trial of Anticarcinoembryonic Antigen Pretargeted Radioimmunotherapy in Progressive Metastatic Medullary Thyroid Carcinoma: Biomarker Response and Survival Improvement.
- Published in:
- Journal of Nuclear Medicine, 2012, v. 53, n. 8, p. 1185, doi. 10.2967/jnumed.111.101865
- By:
- Publication type:
- Article
Comparative Toxicity and Efficacy of Combined Radioimmunotherapy and Antiangiogenic Therapy in Carcinoembryonic Antigen-Expressing Medullary Thyroid Cancer Xenograft.
- Published in:
- Journal of Nuclear Medicine, 2010, v. 51, n. 4, p. 624, doi. 10.2967/jnumed.109.070714
- By:
- Publication type:
- Article
Toxicity and Efficacy of Combined Radioimmunotherapy and Bevacizumab in a Mouse Model of Medullary Thyroid Carcinoma.
- Published in:
- Cancer (0008543X), 2010, v. 116, p. 1053
- By:
- Publication type:
- Article
Pretargeting for imaging and therapy in oncological nuclear medicine.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2017, v. 2, n. 1, p. 1, doi. 10.1186/s41181-017-0026-8
- By:
- Publication type:
- Article
ARRONAX Cyclotron: Setting up of In-House Hospital Radiopharmacy.
- Published in:
- BioMed Research International, 2020, p. 1, doi. 10.1155/2020/1572841
- By:
- Publication type:
- Article
Rhenium-188-labeled anti-neural cell adhesion molecule antibodies with 2-iminothiolane modification for targeting small-cell lung cancer.
- Published in:
- 2000
- By:
- Publication type:
- journal article
Quantitative impact of the first COVID-19 lockdown on nuclear medicine in France: the CORALINE study.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 13, p. 4331, doi. 10.1007/s00259-021-05361-9
- By:
- Publication type:
- Article
Targeting, Toxicity, and Efficacy of 2-Step, Pretargeted Radioimmunotherapy Using a Chimeric Bispecific Antibody and <sup>131</sup>I-Labeled Bivalent Hapten in a Phase I Optimization Clinical Trial.
- Published in:
- Journal of Nuclear Medicine, 2006, v. 47, n. 2, p. 247
- By:
- Publication type:
- Article
Two-Step Targeting of Xenografted Colon Carcinoma Using a Bispecific Antibody and <sup>188</sup>Re-Labeled Bivalent Hapten: Biodistribution and Dosimetry Studies.
- Published in:
- Journal of Nuclear Medicine, 2001, v. 42, n. 1, p. 146
- By:
- Publication type:
- Article
Two-Step Targeting and Dosimetry for Small Cell Lung Cancer Xenograft with Anti-NCAM/Antihistamine Bispecific Antibody and Radioiodinated Bivalent Hapten.
- Published in:
- Journal of Nuclear Medicine, 1999, v. 40, n. 7, p. 1216
- By:
- Publication type:
- Article
Bispecific Antibody and Bivalent Hapten Radioimmunotherapy in CEA-Producing Medullary Thyroid Cancer Xenograft.
- Published in:
- Journal of Nuclear Medicine, 1999, v. 40, n. 1, p. 198
- By:
- Publication type:
- Article
Bispecific Antibody and Iodine-131-Labeled Bivalent Hapten Dosimetry in Patients with Medullary Thyroid or Small-Cell Lung Cancer.
- Published in:
- Journal of Nuclear Medicine, 1996, v. 37, n. 11, p. 1853
- By:
- Publication type:
- Article
Contribution of [64Cu]-ATSM PET in molecular imaging of tumour hypoxia compared to classical [18F]-MISO - a selected review.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Contribution of [64Cu]-ATSM PET in molecular imaging of tumour hypoxia compared to classical [18F]-MISO -- a selected review.
- Published in:
- Nuclear Medicine Review, 2011, v. 14, n. 2, p. 90, doi. 10.5603/NMR.2011.00022
- By:
- Publication type:
- Article